ID   DHB3_HUMAN              Reviewed;         310 AA.
AC   P37058; Q5U0Q6;
DT   01-JUN-1994, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-1995, sequence version 2.
DT   10-MAY-2017, entry version 172.
DE   RecName: Full=Testosterone 17-beta-dehydrogenase 3;
DE            EC=1.1.1.64;
DE   AltName: Full=17-beta-hydroxysteroid dehydrogenase type 3;
DE            Short=17-beta-HSD 3;
DE   AltName: Full=Short chain dehydrogenase/reductase family 12C member 2;
DE   AltName: Full=Testicular 17-beta-hydroxysteroid dehydrogenase;
GN   Name=HSD17B3; Synonyms=EDH17B3, SDR12C2;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND VARIANTS MPH GLN-80;
RP   VAL-203; LEU-232 AND VAL-235.
RC   TISSUE=Testis;
RX   PubMed=8075637; DOI=10.1038/ng0594-34;
RA   Geissler W.M., Davis D.L., Wu L., Bradshaw K.D., Patel S.,
RA   Mendonca B.B., Elliston K.O., Wilson J.D., Russell D.W., Andersson S.;
RT   "Male pseudohermaphroditism caused by mutations of testicular 17 beta-
RT   hydroxysteroid dehydrogenase 3.";
RL   Nat. Genet. 7:34-39(1994).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND VARIANTS ILE-31 AND SER-289.
RG   NIEHS SNPs program;
RL   Submitted (JUL-2003) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RA   Kalnine N., Chen X., Rolfs A., Halleck A., Hines L., Eisenstein S.,
RA   Koundinya M., Raphael J., Moreira D., Kelley T., LaBaer J., Lin Y.,
RA   Phelan M., Farmer A.;
RT   "Cloning of human full-length CDSs in BD Creator(TM) system donor
RT   vector.";
RL   Submitted (OCT-2004) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15164053; DOI=10.1038/nature02465;
RA   Humphray S.J., Oliver K., Hunt A.R., Plumb R.W., Loveland J.E.,
RA   Howe K.L., Andrews T.D., Searle S., Hunt S.E., Scott C.E., Jones M.C.,
RA   Ainscough R., Almeida J.P., Ambrose K.D., Ashwell R.I.S.,
RA   Babbage A.K., Babbage S., Bagguley C.L., Bailey J., Banerjee R.,
RA   Barker D.J., Barlow K.F., Bates K., Beasley H., Beasley O., Bird C.P.,
RA   Bray-Allen S., Brown A.J., Brown J.Y., Burford D., Burrill W.,
RA   Burton J., Carder C., Carter N.P., Chapman J.C., Chen Y., Clarke G.,
RA   Clark S.Y., Clee C.M., Clegg S., Collier R.E., Corby N., Crosier M.,
RA   Cummings A.T., Davies J., Dhami P., Dunn M., Dutta I., Dyer L.W.,
RA   Earthrowl M.E., Faulkner L., Fleming C.J., Frankish A.,
RA   Frankland J.A., French L., Fricker D.G., Garner P., Garnett J.,
RA   Ghori J., Gilbert J.G.R., Glison C., Grafham D.V., Gribble S.,
RA   Griffiths C., Griffiths-Jones S., Grocock R., Guy J., Hall R.E.,
RA   Hammond S., Harley J.L., Harrison E.S.I., Hart E.A., Heath P.D.,
RA   Henderson C.D., Hopkins B.L., Howard P.J., Howden P.J., Huckle E.,
RA   Johnson C., Johnson D., Joy A.A., Kay M., Keenan S., Kershaw J.K.,
RA   Kimberley A.M., King A., Knights A., Laird G.K., Langford C.,
RA   Lawlor S., Leongamornlert D.A., Leversha M., Lloyd C., Lloyd D.M.,
RA   Lovell J., Martin S., Mashreghi-Mohammadi M., Matthews L., McLaren S.,
RA   McLay K.E., McMurray A., Milne S., Nickerson T., Nisbett J.,
RA   Nordsiek G., Pearce A.V., Peck A.I., Porter K.M., Pandian R.,
RA   Pelan S., Phillimore B., Povey S., Ramsey Y., Rand V., Scharfe M.,
RA   Sehra H.K., Shownkeen R., Sims S.K., Skuce C.D., Smith M.,
RA   Steward C.A., Swarbreck D., Sycamore N., Tester J., Thorpe A.,
RA   Tracey A., Tromans A., Thomas D.W., Wall M., Wallis J.M., West A.P.,
RA   Whitehead S.L., Willey D.L., Williams S.A., Wilming L., Wray P.W.,
RA   Young L., Ashurst J.L., Coulson A., Blocker H., Durbin R.M.,
RA   Sulston J.E., Hubbard T., Jackson M.J., Bentley D.R., Beck S.,
RA   Rogers J., Dunham I.;
RT   "DNA sequence and analysis of human chromosome 9.";
RL   Nature 429:369-374(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Brain;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   VARIANTS MPH LEU-65; PRO-176; GLU-205; ILE-208; ASP-215 AND LEU-282.
RX   PubMed=8550739; DOI=10.1210/jcem.81.1.8550739;
RA   Andersson S., Geissler W.M., Wu L., Davis D.L., Grumbach M.M.,
RA   New M.I., Schwarz H.P., Blethen S.L., Mendonca B.B., Bloise W.,
RA   Witchel S.F., Cutler G.B. Jr., Griffin J.E., Wilson J.D., Russel D.W.;
RT   "Molecular genetics and pathophysiology of 17 beta-hydroxysteroid
RT   dehydrogenase 3 deficiency.";
RL   J. Clin. Endocrinol. Metab. 81:130-136(1996).
RN   [7]
RP   VARIANT MPH TRP-80.
RX   PubMed=9758445; DOI=10.1530/eje.0.1390330;
RA   Bilbao J.R., Loridan L., Audi L., Gonzalo E., Castano L.;
RT   "A novel missense (R80W) mutation in 17-beta-hydroxysteroid
RT   dehydrogenase type 3 gene associated with male
RT   pseudohermaphroditism.";
RL   Eur. J. Endocrinol. 139:330-333(1998).
RN   [8]
RP   VARIANTS MPH THR-56 AND SER-130, AND VARIANT SER-289.
RX   PubMed=9709959; DOI=10.1210/jcem.83.8.5052;
RA   Moghrabi N., Hughes I.A., Dunaif A., Andersson S.;
RT   "Deleterious missense mutations and silent polymorphism in the human
RT   17beta-hydroxysteroid dehydrogenase 3 gene (HSD17B3).";
RL   J. Clin. Endocrinol. Metab. 83:2855-2860(1998).
RN   [9]
RP   VARIANT MPH TYR-268.
RX   PubMed=11158067; DOI=10.1210/jcem.86.2.7172;
RA   Lindqvist A., Hughes I.A., Andersson S.;
RT   "Substitution mutation C268Y causes 17 beta-hydroxysteroid
RT   dehydrogenase 3 deficiency.";
RL   J. Clin. Endocrinol. Metab. 86:921-923(2001).
RN   [10]
RP   VARIANT MPH ARG-133, CHARACTERIZATION OF VARIANT MPH ARG-133,
RP   FUNCTION, SUBCELLULAR LOCATION, AND MUTAGENESIS OF GLY-133.
RX   PubMed=26545797; DOI=10.1016/j.jsbmb.2015.10.023;
RA   Engeli R.T., Rhouma B.B., Sager C.P., Tsachaki M., Birk J.,
RA   Fakhfakh F., Keskes L., Belguith N., Odermatt A.;
RT   "Biochemical analyses and molecular modeling explain the functional
RT   loss of 17beta-hydroxysteroid dehydrogenase 3 mutant G133R in three
RT   Tunisian patients with 46, XY Disorders of Sex Development.";
RL   J. Steroid Biochem. Mol. Biol. 155:147-154(2016).
CC   -!- FUNCTION: Favors the reduction of androstenedione to testosterone.
CC       Uses NADPH while the two other EDH17B enzymes use NADH.
CC       {ECO:0000269|PubMed:26545797}.
CC   -!- CATALYTIC ACTIVITY: Testosterone + NADP(+) = androst-4-ene-3,17-
CC       dione + NADPH.
CC   -!- PATHWAY: Hormone biosynthesis; testosterone biosynthesis.
CC   -!- SUBCELLULAR LOCATION: Endoplasmic reticulum
CC       {ECO:0000269|PubMed:26545797}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=P37058-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=P37058-2; Sequence=VSP_056640;
CC         Note=No experimental confirmation available.;
CC   -!- TISSUE SPECIFICITY: Testis.
CC   -!- DISEASE: Male pseudohermaphrodism with gynecomastia (MPH)
CC       [MIM:264300]: These individuals have unambiguous female external
CC       genitalia at birth, but fail to menstruate at the time of expected
CC       puberty and instead virilize as evidenced by growth of the
CC       phallus. Breast development may or may not take place.
CC       {ECO:0000269|PubMed:11158067, ECO:0000269|PubMed:26545797,
CC       ECO:0000269|PubMed:8075637, ECO:0000269|PubMed:8550739,
CC       ECO:0000269|PubMed:9709959, ECO:0000269|PubMed:9758445}. Note=The
CC       disease is caused by mutations affecting the gene represented in
CC       this entry.
CC   -!- SIMILARITY: Belongs to the short-chain dehydrogenases/reductases
CC       (SDR) family. 17-beta-HSD 3 subfamily. {ECO:0000305}.
CC   -!- WEB RESOURCE: Name=NIEHS-SNPs;
CC       URL="http://egp.gs.washington.edu/data/hsd17b3/";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; U05659; AAC50066.1; -; mRNA.
DR   EMBL; AY341031; AAP88937.1; -; Genomic_DNA.
DR   EMBL; BT019371; AAV38178.1; -; mRNA.
DR   EMBL; AL160269; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC034281; AAH34281.1; -; mRNA.
DR   CCDS; CCDS6716.1; -. [P37058-1]
DR   PIR; S43928; S43928.
DR   RefSeq; NP_000188.1; NM_000197.1. [P37058-1]
DR   RefSeq; XP_011516920.1; XM_011518618.2. [P37058-1]
DR   RefSeq; XP_011516921.1; XM_011518619.2. [P37058-1]
DR   RefSeq; XP_016870160.1; XM_017014671.1. [P37058-1]
DR   RefSeq; XP_016870161.1; XM_017014672.1. [P37058-1]
DR   UniGene; Hs.477; -.
DR   ProteinModelPortal; P37058; -.
DR   SMR; P37058; -.
DR   BioGrid; 109526; 10.
DR   IntAct; P37058; 11.
DR   STRING; 9606.ENSP00000364412; -.
DR   BindingDB; P37058; -.
DR   ChEMBL; CHEMBL4234; -.
DR   DrugBank; DB00157; NADH.
DR   SwissLipids; SLP:000001270; -. [P37058-1]
DR   iPTMnet; P37058; -.
DR   PhosphoSitePlus; P37058; -.
DR   BioMuta; HSD17B3; -.
DR   DMDM; 1169300; -.
DR   PaxDb; P37058; -.
DR   PeptideAtlas; P37058; -.
DR   PRIDE; P37058; -.
DR   DNASU; 3293; -.
DR   Ensembl; ENST00000375262; ENSP00000364411; ENSG00000130948. [P37058-2]
DR   Ensembl; ENST00000375263; ENSP00000364412; ENSG00000130948. [P37058-1]
DR   GeneID; 3293; -.
DR   KEGG; hsa:3293; -.
DR   UCSC; uc010msc.1; human. [P37058-1]
DR   CTD; 3293; -.
DR   DisGeNET; 3293; -.
DR   GeneCards; HSD17B3; -.
DR   HGNC; HGNC:5212; HSD17B3.
DR   HPA; HPA056833; -.
DR   MalaCards; HSD17B3; -.
DR   MIM; 264300; phenotype.
DR   MIM; 605573; gene.
DR   neXtProt; NX_P37058; -.
DR   OpenTargets; ENSG00000130948; -.
DR   Orphanet; 752; 46,XY disorder of sex development due to 17-beta-hydroxysteroid dehydrogenase 3 deficiency.
DR   PharmGKB; PA29480; -.
DR   eggNOG; KOG1014; Eukaryota.
DR   eggNOG; COG0300; LUCA.
DR   GeneTree; ENSGT00390000010069; -.
DR   HOGENOM; HOG000039237; -.
DR   HOVERGEN; HBG005478; -.
DR   InParanoid; P37058; -.
DR   KO; K10207; -.
DR   OMA; HFWKVLP; -.
DR   OrthoDB; EOG091G06T2; -.
DR   PhylomeDB; P37058; -.
DR   TreeFam; TF314591; -.
DR   BioCyc; MetaCyc:HS05461-MONOMER; -.
DR   BRENDA; 1.1.1.51; 2681.
DR   BRENDA; 1.1.1.64; 2681.
DR   Reactome; R-HSA-193048; Androgen biosynthesis.
DR   Reactome; R-HSA-75876; Synthesis of very long-chain fatty acyl-CoAs.
DR   UniPathway; UPA00367; -.
DR   GeneWiki; HSD17B3_(gene); -.
DR   GenomeRNAi; 3293; -.
DR   PRO; PR:P37058; -.
DR   Proteomes; UP000005640; Chromosome 9.
DR   Bgee; ENSG00000130948; -.
DR   CleanEx; HS_HSD17B3; -.
DR   ExpressionAtlas; P37058; baseline and differential.
DR   Genevisible; P37058; HS.
DR   GO; GO:0005783; C:endoplasmic reticulum; IDA:UniProtKB.
DR   GO; GO:0005789; C:endoplasmic reticulum membrane; TAS:Reactome.
DR   GO; GO:0043231; C:intracellular membrane-bounded organelle; TAS:ProtInc.
DR   GO; GO:0047045; F:testosterone 17-beta-dehydrogenase (NADP+) activity; IDA:UniProtKB.
DR   GO; GO:0047035; F:testosterone dehydrogenase (NAD+) activity; TAS:Reactome.
DR   GO; GO:0006702; P:androgen biosynthetic process; TAS:Reactome.
DR   GO; GO:0030539; P:male genitalia development; TAS:ProtInc.
DR   GO; GO:0061370; P:testosterone biosynthetic process; IEA:UniProtKB-UniPathway.
DR   InterPro; IPR033281; HSD17B3.
DR   InterPro; IPR016040; NAD(P)-bd_dom.
DR   InterPro; IPR020904; Sc_DH/Rdtase_CS.
DR   InterPro; IPR002347; SDR_fam.
DR   PANTHER; PTHR24322:SF720; PTHR24322:SF720; 1.
DR   Pfam; PF00106; adh_short; 1.
DR   PIRSF; PIRSF000126; 11-beta-HSD1; 1.
DR   PRINTS; PR00081; GDHRDH.
DR   PRINTS; PR00080; SDRFAMILY.
DR   SUPFAM; SSF51735; SSF51735; 1.
DR   PROSITE; PS00061; ADH_SHORT; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Complete proteome; Disease mutation;
KW   Endoplasmic reticulum; Lipid biosynthesis; Lipid metabolism; NADP;
KW   Oxidoreductase; Polymorphism; Pseudohermaphroditism;
KW   Reference proteome; Steroid biosynthesis.
FT   CHAIN         1    310       Testosterone 17-beta-dehydrogenase 3.
FT                                /FTId=PRO_0000054573.
FT   NP_BIND      48     77       NADP. {ECO:0000250}.
FT   ACT_SITE    198    198       Proton acceptor. {ECO:0000255|PROSITE-
FT                                ProRule:PRU10001}.
FT   BINDING     185    185       Substrate. {ECO:0000250}.
FT   VAR_SEQ     225    274       Missing (in isoform 2).
FT                                {ECO:0000303|Ref.3}.
FT                                /FTId=VSP_056640.
FT   VARIANT      31     31       V -> I (in dbSNP:rs2066480).
FT                                {ECO:0000269|Ref.2}.
FT                                /FTId=VAR_014870.
FT   VARIANT      56     56       A -> T (in MPH; Cambridge-2; affects
FT                                NADPH cofactor binding;
FT                                dbSNP:rs119481078).
FT                                {ECO:0000269|PubMed:9709959}.
FT                                /FTId=VAR_016067.
FT   VARIANT      65     65       S -> L (in MPH; dbSNP:rs747329682).
FT                                {ECO:0000269|PubMed:8550739}.
FT                                /FTId=VAR_016068.
FT   VARIANT      80     80       R -> Q (in MPH; Gaza; dbSNP:rs119481075).
FT                                {ECO:0000269|PubMed:8075637}.
FT                                /FTId=VAR_006953.
FT   VARIANT      80     80       R -> W (in MPH; dbSNP:rs119481077).
FT                                {ECO:0000269|PubMed:9758445}.
FT                                /FTId=VAR_006954.
FT   VARIANT     130    130       N -> S (in MPH; Cambridge-1; complete
FT                                loss of activity; dbSNP:rs119481079).
FT                                {ECO:0000269|PubMed:9709959}.
FT                                /FTId=VAR_016069.
FT   VARIANT     133    133       G -> R (in MPH; almost complete loss of
FT                                testosterone 17-beta-dehydrogenase
FT                                (NADP+) activity; no effect on protein
FT                                abundance; no effect on endoplasmic
FT                                reticulum location; dbSNP:rs747724352).
FT                                {ECO:0000269|PubMed:26545797}.
FT                                /FTId=VAR_075369.
FT   VARIANT     176    176       Q -> P (in MPH; dbSNP:rs767259718).
FT                                {ECO:0000269|PubMed:8550739}.
FT                                /FTId=VAR_016070.
FT   VARIANT     203    203       A -> V (in MPH; dbSNP:rs119481076).
FT                                {ECO:0000269|PubMed:8075637}.
FT                                /FTId=VAR_006955.
FT   VARIANT     205    205       V -> E (in MPH; dbSNP:rs372027264).
FT                                {ECO:0000269|PubMed:8550739}.
FT                                /FTId=VAR_016071.
FT   VARIANT     208    208       F -> I (in MPH).
FT                                {ECO:0000269|PubMed:8550739}.
FT                                /FTId=VAR_016072.
FT   VARIANT     215    215       E -> D (in MPH; dbSNP:rs115063639).
FT                                {ECO:0000269|PubMed:8550739}.
FT                                /FTId=VAR_016203.
FT   VARIANT     232    232       S -> L (in MPH; dbSNP:rs28939085).
FT                                {ECO:0000269|PubMed:8075637}.
FT                                /FTId=VAR_006956.
FT   VARIANT     235    235       M -> V (in MPH; dbSNP:rs119481074).
FT                                {ECO:0000269|PubMed:8075637}.
FT                                /FTId=VAR_006957.
FT   VARIANT     268    268       C -> Y (in MPH; complete loss of
FT                                activity; dbSNP:rs119481080).
FT                                {ECO:0000269|PubMed:11158067}.
FT                                /FTId=VAR_016073.
FT   VARIANT     282    282       P -> L (in MPH; dbSNP:rs144809928).
FT                                {ECO:0000269|PubMed:8550739}.
FT                                /FTId=VAR_016074.
FT   VARIANT     289    289       G -> C (in dbSNP:rs2066479).
FT                                /FTId=VAR_061844.
FT   VARIANT     289    289       G -> R (in dbSNP:rs2066479).
FT                                /FTId=VAR_061845.
FT   VARIANT     289    289       G -> S (in dbSNP:rs2066479).
FT                                {ECO:0000269|PubMed:9709959,
FT                                ECO:0000269|Ref.2}.
FT                                /FTId=VAR_014871.
FT   MUTAGEN     133    133       G->A: Has 70% of wild-type testosterone
FT                                17-beta-dehydrogenase (NADP+) activity.
FT                                {ECO:0000269|PubMed:26545797}.
FT   MUTAGEN     133    133       G->F: Almost complete loss of
FT                                testosterone 17-beta-dehydrogenase
FT                                (NADP+) activity.
FT                                {ECO:0000269|PubMed:26545797}.
FT   MUTAGEN     133    133       G->Q: Almost complete loss of
FT                                testosterone 17-beta-dehydrogenase
FT                                (NADP+) activity.
FT                                {ECO:0000269|PubMed:26545797}.
SQ   SEQUENCE   310 AA;  34516 MW;  0643FF35ED979185 CRC64;
     MGDVLEQFFI LTGLLVCLAC LAKCVRFSRC VLLNYWKVLP KSFLRSMGQW AVITGAGDGI
     GKAYSFELAK RGLNVVLISR TLEKLEAIAT EIERTTGRSV KIIQADFTKD DIYEHIKEKL
     AGLEIGILVN NVGMLPNLLP SHFLNAPDEI QSLIHCNITS VVKMTQLILK HMESRQKGLI
     LNISSGIALF PWPLYSMYSA SKAFVCAFSK ALQEEYKAKE VIIQVLTPYA VSTAMTKYLN
     TNVITKTADE FVKESLNYVT IGGETCGCLA HEILAGFLSL IPAWAFYSGA FQRLLLTHYV
     AYLKLNTKVR
//
